Filter Results:
(44)
Show Results For
- All HBS Web
(187)
- People (1)
- News (44)
- Research (84)
- Events (3)
- Multimedia (8)
- Faculty Publications (52)
Show Results For
- All HBS Web
(187)
- People (1)
- News (44)
- Research (84)
- Events (3)
- Multimedia (8)
- Faculty Publications (52)
Page 1 of 44
Results →
Sort by
- 13 Feb 2023
- News
Alumnus Gift Will Nurture Basic, Therapeutic Science
Swiss biotech executive, entrepreneur, and philanthropist Ernesto Bertarelli (MBA 1993) has pledged $75 million to advance basic scientific discovery, therapeutic science, and a culture of entrepreneurship at Harvard Medical School. The... View Details
- 07 Jun 2023
- News
Martine Rothblatt: Making Implausible Dreams Reality
- 01 Dec 2023
- News
Wide Horizon
studies the relationship between the gut microbiome and ASD, and whose work N of One also supports. “That’s constricted funding and therefore growth in this field.” This microbiome research has led to a therapeutic (currently in Phase II... View Details
Keywords: Dan Morrell; Photos by Sarah Wilson
- 01 Dec 2023
- News
Drop Everything, Read This
psychiatrist Palmer’s thesis that “mental disorders are metabolic disorders of the brain” provides new therapeutic pathways based on a rigorous synthesis of existing literature. Low-cost, low-risk lifestyle interventions include sleep,... View Details
- 01 Mar 2024
- News
The War Within
psychiatric treatments for PTSD and found Michael Pollan’s How to Change Your Mind, about the new science of psychedelic drugs. “I am not an ‘underground person’ by nature, but I knew I had nothing to lose,” she says. Ames connected with medical practitioners who were... View Details
- 31 Jan 2014
- News
Body, Heal Thyself
check—ideally a patient can be injected with Moderna's mRNA, which offers directions, or a specific recipe, to individual cells, which then use it to produce the protein or antibody needed to tackle the problem. In other words, mRNA View Details
- 01 Jun 2023
- News
From Big Pharma to Startup
Hunter Goble (MBA 2022) did not enroll in Harvard Business School with dreams of becoming an entrepreneur. After earning his MBA, Goble intended to return to Eli Lilly to continue to work building brands and launching products. He envisioned himself leading a big,... View Details
Keywords: April White
- 23 Jan 2019
- News
The Promise of Personalized Medicine
as a biotechnology company, Myofinity Biosciences. Those two organizations have taken two different paths. They’re not connected. The 501(c)(3), Terry’s Foundation (now Cure Rare Disease), is doing something incredibly unprecedented. What that is, is it’s trying to... View Details
- 06 Sep 2016
- News
Horse-Powered Healing
Finance strategist Elizabeth Coit (MBA 1991) took her career in an unexpected direction six years ago, when she became executive director of the Morning Dove Therapeutic Riding Center in Zionsville, Indiana. “At some point, I decided I... View Details
- 26 Feb 2020
- News
Alumni-Led Biotech Developing Vaccine to Combat Coronavirus
As reported in the Boston Globe, Stéphane Bancel (MBA 2000, AMP 170) and his firm Moderna Therapeutics are working with the National Institutes of Health (NIH) to develop a vaccine for coronavirus. Vials of its vaccine, the company told... View Details
- 25 Apr 2014
- News
A revolution in healing
proteins. Moderna's mRNA Therapeutics gives patients' cells the code they need to begin creating their own proteins and antibodies to fight disease, allowing the body to heal itself. "We believe we have a chance to do something... View Details
- 01 Dec 2019
- News
The Race Against Resistance
with the rise of antibiotic-resistant superbugs. “We are approaching a cliff,” says Anna Diaz Triola (MBA 2000), vice president of marketing at Summit Therapeutics in Cambridge, Massachusetts, which is part of a cohort of small pharma... View Details
Keywords: Lisa Scanlon Mogolov
- 20 Jul 2017
- News
Life Lab Nurtures Early Stage Startup Day Zero Diagnostics
ability to treat patients with targeted therapeutics within hours of being admitted to the hospital—on Day Zero. The five-member founding team includes two MD PhDs who specialize in infectious disease (Doug Kwon) and clinical pathology... View Details
- 23 Mar 2016
- News
Building a Biotech Business from Farmed Fish
Charlton Ames (MBA 1970) is chairman and vice president of business development for Sea Run Holdings, a virtual firm in Maine that develops innovative biologics and therapeutics from the blood of farmed salmon. In this video he explains... View Details
- 01 Dec 2013
- News
To Market, to Market
Inhibitors of proteins that play an important role in cholesterol and fat metabolism, to be developed as potential therapeutics for the treatment of diseases such as metabolic syndrome, type 2 diabetes, coronary artery disease, and some... View Details
- 23 Mar 2016
- News
Curing Parkinson’s Disease
HBS alumni Jonathan Solomon and Hampus Hillerstrom (both MBA 2007) play an important role in Jon Palfreman’s recent book Brain Storms: The Race to Unlock the Mysteries of Parkinson’s Disease. As the cofounders of NeuroPhage Pharmaceuticals, the pair is working to... View Details
- 01 Dec 2004
- News
The Future of Stem Cells
cardiovascular disease. In addition, apart from any possible therapeutic benefits, embryonic stem-cell research could play a central role in helping to understand the nature and development of disease generally. Spar, the Spangler Family... View Details
Keywords: Garry Emmons
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
communicating appropriately to maximize the therapeutic effects. The electrodes are placed inside the brain at the precise spot where the issue originates and communicate to a wireless monitor that tracks the neurotransmitter changes to... View Details
Keywords: Janelle Nanos
- 03 Nov 2016
- News
17 Ventures Join the Pagliuca Harvard Life Lab
Institute/HMS Nix – HBS, SEAS, Blavatnik Fellow PathoVax – HMS Piper Therapeutics – College, HBS Riparian Pharmaceuticals – College, SEAS Suono Bio – HMS UnNamed – HMS UrSure Inc. – HKS Vaxess Technologies, Inc. HBS, SEAS, HKS, HLS... View Details